Correction

The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations (vol 264, pg 2351, 2017)

Journal

JOURNAL OF NEUROLOGY
Volume 264, Issue 12, Pages 2375-2377

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-017-8633-6

Keywords

-

Ask authors/readers for more resources

Unfortunately, the online published article has errors in Table 2. The Peginterferon is listed as IM, when it should be SC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available